Key risks
- Net profit collapsed 51% in 9 months (₹819.54 Cr in Sep 2025 to ₹403.17 Cr in Jun 2026) despite 3.5% revenue growth, signalling margin compression or deteriorating underwriting experience—verify loss ratios and claims trends.
- EPS halved from ₹16.49 to ₹8.08 over the same period; stock down 14.36% over 1 year while paying regular dividends, raising questions about sustainability—verify cash-flow adequacy and payout ratios.
- PE of 33.52 with declining earnings suggests valuation disconnect; investors may be pricing in a recovery that has not yet materialised—verify visibility on profit stabilisation.
- Regulatory rate controls, mandatory coverage mandates, or solvency tightening can cap margins; verify recent IRDA policy changes and competitive pricing pressure in the general-insurance market.
Generated analysis · source review pending